aPDT |
Antimicrobial photodynamic therapy |
BOP |
Bleeding on probing |
BTF |
Bio-enhanced turmeric formulation |
CAL |
Clinical attachment level |
CMS |
Carboxymethyl starch |
COX-2 |
Cyclooxygenase-2 |
CS |
Chitosan |
CRP |
C-reactive protein |
DNA |
Deoxyribonucleic acid |
EGF |
Epidermal growth factor |
EMT |
Epithelial–mesenchymal transition |
GI |
Gingival index |
HNC |
Head and neck cancer |
IL-1β |
Interleukin 1β |
IL-6 |
Interleukin-6 |
IL-8 |
Interleukin-8 |
LDD |
Local drug delivery |
MA |
Mefenamic acid |
MDA |
Malondialdehyde |
MDSC |
Myeloid-derived suppressor cells |
MF |
Mucosal flexibility |
MIT |
Modified intention to treat |
MMT |
Montmorillonite |
MO |
Mouth opening |
MOMI |
Modified oral mucositis index |
NF- κB |
Nuclear factor kappa B |
NRS |
Numerical rating scale |
OLP |
Oral lichen planus |
OPMDs |
Oral potentially malignant disorders |
OSCC |
Oral squamous carcinoma |
OSMF |
Oral submucosal fibrosis |
PBM |
Photobiomodulation |
PCT |
Procalcitonin |
PI |
Plaque index |
PLA |
Poly lactide |
PLGA |
Poly lactide-co-glicolide |
PP |
Per protocol |
PPD |
Periodontal probing depth |
RANK |
Receptor activator of nuclear factor κB |
RANKL |
Receptor activator of nuclear factor κΒ ligand |
RAS |
Recurrent aphthous stomatitis |
RIOM |
Radiation-induced oral mucositis |
ROS |
Reactive oxygen species |
PLGA |
Poly lactide-co-glicolide |
SRP |
Scaling and root planing |
SPT |
Surgical periodontal therapy |
TGF-β |
Transforming growth factor β |
TP |
Tongue protrusion |
VAS |
Visual analog scale |
8-OHdG |
8-hydroxydeoxyguanosine |